Live Breaking News & Updates on Intratumoral Tigilanol Tiglate

Stay updated with breaking news from Intratumoral tigilanol tiglate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Grants Orphan Drug Designation to Tigilanol Tiglate in Soft Tissue Sarcoma

The FDA has granted an orphan drug designation to tigilanol tiglate for the treatment of patients with soft tissue sarcoma. ....

Intratumoral Tigilanol Tiglate , Qbiotics Group , Strategic Alliances , Investor Relations , Drug Designation , Orphan Drug Designation , Clinical Study , Soft Tissue , Fda Orphan Drug Designation , Tigilanol Tiglate , Soft Tissue Sarcoma ,

FDA Grants Orphan Drug Designation to Tigilanol Tiglate for Soft Tissue Sarcoma

Tigilanol tiglate is a novel, small molecule drug for the intratumoral treatment of solid tumors, inducing tumor cell death and stimulating immune response. ....

Intratumoral Tigilanol Tiglate , Trial Name , Clinical Study , Soft Tissue ,